register

Marketing & Strategy

PRIME Awards 2020 call for entries – deadline extended

Health Industry Hub | April 22, 2020 |

Marketing & Strategy: The PRIME Awards, the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries with key dates below.

Chair of Judges, Mr David Cousins, returns to oversee and facilitate judging, which this year broadens the review process with a mix of new and returning judges, all highly experienced in their field.

“I’m excited to follow up on the success of 2019 where we had our biggest year ever. To continue to ensure that the highest calibre of work is recognised, in 2020 we have evolved the judging process to a two-stage approach and welcomed new judges,” said Mr Cousins.

In light of the current COVID-19 restrictions, a decision will be made closer to the time regarding the format of the awards ceremony.

“Whilst the current situation is making the future seem uncertain, the PRIME Awards gives us time to reflect on our hard work and ultimately celebrate success – no matter what medium the awards ceremony may be held in” said Mr Cousins.

“Pausing to recognise innovation, collaboration and success in our industry is critical to increasing knowledge and skill as a whole.”

KEY INFORMATION

Entries Open Now and Close
Thursday 25th June

Finalists Announced
Early August

Awards Ceremony
Thursday 24th September

There are 18 categories for teams and individuals within the pharmaceutical and life sciences industry to shine. Full details of the categories and the entry kit can be found at www.primeawards.com.au


Medical

NSW Health to settle class action

NSW Health to settle ‘largest’ class action

Health Industry Hub | April 29, 2024 |

A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]

More


News & Trends - Pharmaceuticals

Lilly's first-in-class therapy PBS listed for early breast cancer after 15-year gap

Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap

Health Industry Hub | April 29, 2024 |

Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]

More


News & Trends - Pharmaceuticals

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

Health Industry Hub | April 29, 2024 |

Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]

More


News & Trends - Pharmaceuticals

PBAC recommendation to reshape prescribing in heart failure

PBAC recommendation to reshape prescribing in heart failure

Health Industry Hub | April 29, 2024 |

Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]

More


This content is copyright protected. Please subscribe to gain access.